ALLO SG&A Expense Growth
Allogene Therapeutics Inc · SG&A Expense Growth
ALLO SG&A Expense Growth
Latest reported-12.92%period ending
ALLO FY SG&A Growth (YoY) (0.00% → -12.92%)
Latest values, visible window
High-resolution chart · PNG
ALLO sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -12.9193% | |
| -9.0243% | |
| -9.6236% | |
| 7.0171% | |
| 13.5604% | |
| 13.542% | |
| 40.2396% | |
| 2,049,000% | |
| 0% |